vs

Side-by-side financial comparison of CITIZENS, INC. (CIA) and VIEMED HEALTHCARE, INC. (VMD). Click either name above to swap in a different company.

VIEMED HEALTHCARE, INC. is the larger business by last-quarter revenue ($76.2M vs $72.1M, roughly 1.1× CITIZENS, INC.). CITIZENS, INC. runs the higher net margin — 10.2% vs 7.4%, a 2.8% gap on every dollar of revenue. On growth, VIEMED HEALTHCARE, INC. posted the faster year-over-year revenue change (25.5% vs 13.5%). CITIZENS, INC. produced more free cash flow last quarter ($17.5M vs $9.7M). Over the past eight quarters, VIEMED HEALTHCARE, INC.'s revenue compounded faster (22.7% CAGR vs 11.7%).

Citizen Watch Co., Ltd. , also known as the Citizen Group, is an electronics company primarily known for its watches and is the core company of a Japanese global corporate group based in Nishitokyo, Tokyo, Japan. In addition to Citizen brand watches, it is the parent of American watch company Bulova. Beyond watches, Citizen also manufactures calculators, printers, health care devices, and precision CNC machining equipment.

Viemed Healthcare, Inc. is a medical technology firm specializing in respiratory care solutions. It develops, manufactures and distributes portable ventilators, respiratory therapy devices and related support services, catering to acute care, post-acute care and home care segments across North America, Europe and key Asia-Pacific markets for patients with respiratory conditions.

CIA vs VMD — Head-to-Head

Bigger by revenue
VMD
VMD
1.1× larger
VMD
$76.2M
$72.1M
CIA
Growing faster (revenue YoY)
VMD
VMD
+12.0% gap
VMD
25.5%
13.5%
CIA
Higher net margin
CIA
CIA
2.8% more per $
CIA
10.2%
7.4%
VMD
More free cash flow
CIA
CIA
$7.8M more FCF
CIA
$17.5M
$9.7M
VMD
Faster 2-yr revenue CAGR
VMD
VMD
Annualised
VMD
22.7%
11.7%
CIA

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CIA
CIA
VMD
VMD
Revenue
$72.1M
$76.2M
Net Profit
$7.3M
$5.6M
Gross Margin
57.9%
Operating Margin
10.9%
11.0%
Net Margin
10.2%
7.4%
Revenue YoY
13.5%
25.5%
Net Profit YoY
102.7%
30.7%
EPS (diluted)
$0.14

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CIA
CIA
VMD
VMD
Q4 25
$72.1M
$76.2M
Q3 25
$62.8M
$71.9M
Q2 25
$65.1M
$63.1M
Q1 25
$55.7M
$59.1M
Q4 24
$63.5M
$60.7M
Q3 24
$61.7M
$58.0M
Q2 24
$62.1M
$55.0M
Q1 24
$57.7M
$50.6M
Net Profit
CIA
CIA
VMD
VMD
Q4 25
$7.3M
$5.6M
Q3 25
$2.4M
$3.5M
Q2 25
$6.5M
$3.2M
Q1 25
$-1.6M
$2.6M
Q4 24
$3.6M
$4.3M
Q3 24
$2.8M
$3.9M
Q2 24
$4.0M
$1.5M
Q1 24
$4.5M
$1.6M
Gross Margin
CIA
CIA
VMD
VMD
Q4 25
57.9%
Q3 25
57.5%
Q2 25
58.3%
Q1 25
56.3%
Q4 24
59.5%
Q3 24
59.3%
Q2 24
59.8%
Q1 24
58.9%
Operating Margin
CIA
CIA
VMD
VMD
Q4 25
10.9%
11.0%
Q3 25
7.1%
7.8%
Q2 25
10.6%
8.1%
Q1 25
-3.2%
6.5%
Q4 24
5.9%
10.6%
Q3 24
4.9%
9.7%
Q2 24
5.3%
6.6%
Q1 24
8.5%
4.4%
Net Margin
CIA
CIA
VMD
VMD
Q4 25
10.2%
7.4%
Q3 25
3.8%
4.9%
Q2 25
9.9%
5.0%
Q1 25
-2.9%
4.4%
Q4 24
5.7%
7.1%
Q3 24
4.5%
6.7%
Q2 24
6.4%
2.7%
Q1 24
7.9%
3.2%
EPS (diluted)
CIA
CIA
VMD
VMD
Q4 25
$0.14
Q3 25
$0.09
Q2 25
$0.08
Q1 25
$0.06
Q4 24
$0.10
Q3 24
$0.10
Q2 24
$0.04
Q1 24
$0.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CIA
CIA
VMD
VMD
Cash + ST InvestmentsLiquidity on hand
$23.0M
$13.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$235.0M
$141.5M
Total Assets
$1.8B
$199.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CIA
CIA
VMD
VMD
Q4 25
$23.0M
$13.5M
Q3 25
$23.1M
$11.1M
Q2 25
$22.7M
$20.0M
Q1 25
$18.4M
$10.2M
Q4 24
$29.3M
$17.5M
Q3 24
$32.4M
$11.3M
Q2 24
$26.3M
$8.8M
Q1 24
$23.2M
$7.3M
Stockholders' Equity
CIA
CIA
VMD
VMD
Q4 25
$235.0M
$141.5M
Q3 25
$225.6M
$133.6M
Q2 25
$229.0M
$139.7M
Q1 25
$218.1M
$134.8M
Q4 24
$210.4M
$131.4M
Q3 24
$207.6M
$125.0M
Q2 24
$191.5M
$119.4M
Q1 24
$195.2M
$116.3M
Total Assets
CIA
CIA
VMD
VMD
Q4 25
$1.8B
$199.2M
Q3 25
$1.7B
$202.4M
Q2 25
$1.7B
$184.6M
Q1 25
$1.7B
$178.1M
Q4 24
$1.7B
$177.1M
Q3 24
$1.7B
$169.5M
Q2 24
$1.7B
$163.9M
Q1 24
$1.7B
$154.9M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CIA
CIA
VMD
VMD
Operating Cash FlowLast quarter
$18.0M
$18.4M
Free Cash FlowOCF − Capex
$17.5M
$9.7M
FCF MarginFCF / Revenue
24.3%
12.7%
Capex IntensityCapex / Revenue
0.6%
11.5%
Cash ConversionOCF / Net Profit
2.45×
3.27×
TTM Free Cash FlowTrailing 4 quarters
$26.1M
$11.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CIA
CIA
VMD
VMD
Q4 25
$18.0M
$18.4M
Q3 25
$4.7M
$18.4M
Q2 25
$3.5M
$12.3M
Q1 25
$748.0K
$2.9M
Q4 24
$31.9M
$15.0M
Q3 24
$9.7M
$12.7M
Q2 24
$4.6M
$10.2M
Q1 24
$6.8M
$1.2M
Free Cash Flow
CIA
CIA
VMD
VMD
Q4 25
$17.5M
$9.7M
Q3 25
$4.6M
$10.7M
Q2 25
$3.3M
$4.1M
Q1 25
$641.0K
$-12.6M
Q4 24
$31.3M
$3.2M
Q3 24
$9.3M
$1.7M
Q2 24
$4.5M
$1.2M
Q1 24
$6.7M
$-4.8M
FCF Margin
CIA
CIA
VMD
VMD
Q4 25
24.3%
12.7%
Q3 25
7.3%
14.9%
Q2 25
5.1%
6.5%
Q1 25
1.2%
-21.4%
Q4 24
49.2%
5.2%
Q3 24
15.1%
3.0%
Q2 24
7.2%
2.3%
Q1 24
11.7%
-9.5%
Capex Intensity
CIA
CIA
VMD
VMD
Q4 25
0.6%
11.5%
Q3 25
0.1%
10.6%
Q2 25
0.3%
12.9%
Q1 25
0.2%
26.2%
Q4 24
1.0%
19.5%
Q3 24
0.6%
19.0%
Q2 24
0.2%
16.3%
Q1 24
0.1%
11.9%
Cash Conversion
CIA
CIA
VMD
VMD
Q4 25
2.45×
3.27×
Q3 25
1.93×
5.23×
Q2 25
0.54×
3.88×
Q1 25
1.09×
Q4 24
8.81×
3.47×
Q3 24
3.48×
3.29×
Q2 24
1.16×
6.94×
Q1 24
1.49×
0.73×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons